Novel interactions between the 5‐HT transporter, 5‐HT 1B receptors and Rho kinase in vivo and in pulmonary fibroblasts

Background and purpose: While the 5‐HT and Rho‐kinase (ROCK) pathways have been implicated in the development of pulmonary arterial hypertension (PAH), the nature of any interactions between them remain unclear. This study investigated a role for ROCK in 5‐HT‐regulated proliferative responses in lun...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of pharmacology Vol. 155; no. 4; pp. 606 - 616
Main Authors Mair, K M, MacLean, M R, Morecroft, I, Dempsie, Y, Palmer, T M
Format Journal Article
LanguageEnglish
Published 29.01.2009
Online AccessGet full text

Cover

Loading…
Abstract Background and purpose: While the 5‐HT and Rho‐kinase (ROCK) pathways have been implicated in the development of pulmonary arterial hypertension (PAH), the nature of any interactions between them remain unclear. This study investigated a role for ROCK in 5‐HT‐regulated proliferative responses in lung fibroblasts in vivo and in vitro . Experimental approach: PAH was examined in mice over‐expressing human 5‐HT transporters (SERT+), from which pulmonary artery fibroblasts (PFs) were isolated to assess ROCK expression. In vitro analysis of 5‐HT signalling employed CCL39 hamster lung fibroblasts. Key results: ROCK inhibition ablated increased pulmonary remodelling and hypertension observed in SERT+ mice, and ROCK1/2 protein levels were elevated in SERT+ PFs. ROCK inhibition also reduced 5‐HT‐stimulated proliferation by suppressing MEK‐stimulated ERK phosphorylation. While optimal 5‐HT‐stimulated proliferation required 5‐HT 1B and 5‐HT 2A receptors and SERT, receptor sensitivity to Y27632 was restricted to the 5‐HT 1B receptor. Also, while hypoxia‐induced pulmonary vascular remodelling and hypertension were sensitive to Y27632 in WT and SERT+ animals, the proportions sensitive to ROCK inhibition were increased by SERT over‐expression. Conclusions and implications: SERT over‐expression increased ROCK‐dependent pulmonary remodelling in normoxia and hypoxia and SERT over‐expression was associated with elevated ROCK1/2 levels. ROCK also potentiated 5‐HT 1B receptor‐stimulated ERK activation and proliferation in vitro by facilitating MEK‐ERK interaction. British Journal of Pharmacology (2008) 155 , 606–616; doi: 10.1038/bjp.2008.310 ; published online 11 August 2008
AbstractList Background and purpose: While the 5‐HT and Rho‐kinase (ROCK) pathways have been implicated in the development of pulmonary arterial hypertension (PAH), the nature of any interactions between them remain unclear. This study investigated a role for ROCK in 5‐HT‐regulated proliferative responses in lung fibroblasts in vivo and in vitro . Experimental approach: PAH was examined in mice over‐expressing human 5‐HT transporters (SERT+), from which pulmonary artery fibroblasts (PFs) were isolated to assess ROCK expression. In vitro analysis of 5‐HT signalling employed CCL39 hamster lung fibroblasts. Key results: ROCK inhibition ablated increased pulmonary remodelling and hypertension observed in SERT+ mice, and ROCK1/2 protein levels were elevated in SERT+ PFs. ROCK inhibition also reduced 5‐HT‐stimulated proliferation by suppressing MEK‐stimulated ERK phosphorylation. While optimal 5‐HT‐stimulated proliferation required 5‐HT 1B and 5‐HT 2A receptors and SERT, receptor sensitivity to Y27632 was restricted to the 5‐HT 1B receptor. Also, while hypoxia‐induced pulmonary vascular remodelling and hypertension were sensitive to Y27632 in WT and SERT+ animals, the proportions sensitive to ROCK inhibition were increased by SERT over‐expression. Conclusions and implications: SERT over‐expression increased ROCK‐dependent pulmonary remodelling in normoxia and hypoxia and SERT over‐expression was associated with elevated ROCK1/2 levels. ROCK also potentiated 5‐HT 1B receptor‐stimulated ERK activation and proliferation in vitro by facilitating MEK‐ERK interaction. British Journal of Pharmacology (2008) 155 , 606–616; doi: 10.1038/bjp.2008.310 ; published online 11 August 2008
Author Palmer, T M
MacLean, M R
Dempsie, Y
Mair, K M
Morecroft, I
Author_xml – sequence: 1
  givenname: K M
  surname: Mair
  fullname: Mair, K M
– sequence: 2
  givenname: M R
  surname: MacLean
  fullname: MacLean, M R
– sequence: 3
  givenname: I
  surname: Morecroft
  fullname: Morecroft, I
– sequence: 4
  givenname: Y
  surname: Dempsie
  fullname: Dempsie, Y
– sequence: 5
  givenname: T M
  surname: Palmer
  fullname: Palmer, T M
BookMark eNo1kE1OwzAUhC1UJNrCjgP4AE14r04cZwkVUKQKJFTWkR07akpqR7YpghVH4IychJSf1RvNjEZP34SMrLOGkHOEFIGJC7Xt0zmASBnCERljVvAkZwJHZAwARYIoxAmZhLAFGMIiH5P3e7c3HW1tNF7WsXU2UGXiqzGWxo2h-dfH53JNo5c29M4Prdm_h1fUm9r00flApdX0cePoc2tlMMMe3bd792MPun_pds5K_0abVnmnOhliOCXHjeyCOfu7U_J0c71eLJPVw-3d4nKV1JhDTErRoC6wLBUzc5RS6YKVXPCcZ02J3PAmnyMXOXCFqlEoeAZQlloL1BnTkk3J7He39i4Eb5qq9-1ueKZCqA7cqoFbdeBWDdzYNzUkZNw
CitedBy_id crossref_primary_10_2147_JEP_S236743
crossref_primary_10_1007_s00109_013_0998_0
crossref_primary_10_1111_j_1476_5381_2009_00283_x
crossref_primary_10_1161_ATVBAHA_116_308929
crossref_primary_10_1016_j_pbiomolbio_2012_05_009
crossref_primary_10_1016_j_vph_2010_09_003
crossref_primary_10_1111_bph_15275
crossref_primary_10_1139_y2012_108
crossref_primary_10_1161_CIRCULATIONAHA_108_847707
crossref_primary_10_1152_physiol_00039_2019
crossref_primary_10_1093_cvr_cvp306
crossref_primary_10_1155_2020_1478291
crossref_primary_10_1152_ajpregu_00126_2012
crossref_primary_10_1016_j_jare_2021_11_011
crossref_primary_10_1586_17512433_1_6_749
crossref_primary_10_3389_fnana_2020_00026
crossref_primary_10_1016_j_neuroimage_2015_01_049
crossref_primary_10_1007_s00228_012_1314_6
crossref_primary_10_1152_ajplung_00043_2013
crossref_primary_10_1111_j_1476_5381_2011_01305_x
crossref_primary_10_1038_pr_2013_73
crossref_primary_10_1164_rccm_201206_1028OC
crossref_primary_10_1016_j_bmcl_2019_05_006
crossref_primary_10_1016_j_pupt_2010_09_001
crossref_primary_10_1152_ajplung_00198_2011
crossref_primary_10_1113_expphysiol_2012_065474
crossref_primary_10_1164_rccm_201412_2148OC
crossref_primary_10_1016_j_pupt_2014_01_002
crossref_primary_10_3390_ijms19071891
crossref_primary_10_1002_wmts_50
Cites_doi 10.1038/79226
10.1164/rccm.200509-1361OC
10.1161/hh2401.100426
10.1124/jpet.104.081182
10.1002/path.1711600204
10.1007/s10254-004-0034-4
10.1152/japplphysiol.01028.2005
10.1074/jbc.M702637200
10.1152/ajplung.00234.2007
10.1152/ajplung.1999.277.2.L282
10.1128/MCB.02061-05
10.1172/JCI200112805
10.1253/circj.70.174
10.1164/ajrccm.162.4.9912131
10.1111/j.1476-5381.1996.tb15982.x
10.1161/01.CIR.0000127375.56172.92
10.1038/sj.bjp.0703570
10.1136/jmg.40.12.865
10.1161/01.RES.0000141428.53262.a4
10.1016/j.neulet.2006.08.038
10.1161/01.RES.0000261658.12024.18
10.1016/S0092-8674(03)01014-6
10.1161/01.RES.0000176025.57706.1e
10.1620/tjem.211.309
10.1111/j.1476-5381.1996.tb15760.x
10.1152/ajpcell.00459.2005
10.1172/JCI8678
10.1152/ajplung.00090.2003
10.1097/FJC.0b013e31802df112
10.1097/01.fjc.0000248244.64430.4a
10.1165/rcmb.2005-0163OC
10.1242/jcs.03266
10.1161/01.RES.0000222546.45372.a0
10.1164/rccm.200405-637OC
10.1016/S0891-5849(97)00359-6
10.1161/01.RES.0000111804.34509.94
10.1161/01.RES.0000215809.47923.fd
10.1161/01.RES.0000174287.17953.83
10.1074/jbc.M604195200
10.1002/path.1427
10.1097/FJC.0b013e3181593774
10.1164/rccm.200302-264OC
10.1152/physiol.00053.2005
10.1016/0014-5793(96)00811-3
10.1038/sj.bjp.0706408
10.1152/ajplung.00110.2006
10.1038/sj.bjp.0702841
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.1038/bjp.2008.310
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1476-5381
EndPage 616
ExternalDocumentID 10_1038_bjp_2008_310
GroupedDBID ---
.3N
05W
0R~
1OC
23N
24P
2WC
33P
36B
3O-
3SF
4.4
52U
52V
53G
5GY
6J9
8-0
8-1
8UM
A00
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAYXX
AAZKR
ABCUV
ABDBF
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
AOIJS
ATUGU
AZBYB
AZVAB
B0M
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BRXPI
C45
CAG
CITATION
COF
CS3
DCZOG
DIK
DRFUL
DRMAN
DRSTM
DU5
E3Z
EAD
EAP
EAS
EBC
EBD
EBS
ECV
EJD
EMB
EMK
EMOBN
ENC
ESX
F5P
FUBAC
G-S
GODZA
GX1
H.X
HGLYW
HYE
HZ~
KBYEO
LATKE
LEEKS
LH4
LITHE
LOXES
LSO
LUTES
LW6
LYRES
MEWTI
MK0
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
MY~
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P4E
Q.N
QB0
RIG
ROL
RPM
RWI
SJN
SUPJJ
SV3
TEORI
TR2
TUS
UPT
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WVDHM
WXSBR
XV2
YHG
ZGI
ZZTAW
~8M
~S-
ID FETCH-LOGICAL-c150t-98f1d7199b3e21aabd739686564f916e6f52168506b1bfb18640099dd81d43da3
ISSN 0007-1188
IngestDate Fri Aug 23 00:36:17 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c150t-98f1d7199b3e21aabd739686564f916e6f52168506b1bfb18640099dd81d43da3
PageCount 11
ParticipantIDs crossref_primary_10_1038_bjp_2008_310
PublicationCentury 2000
PublicationDate 2009-01-29
PublicationDateYYYYMMDD 2009-01-29
PublicationDate_xml – month: 01
  year: 2009
  text: 2009-01-29
  day: 29
PublicationDecade 2000
PublicationTitle British journal of pharmacology
PublicationYear 2009
References e_1_2_8_28_1
e_1_2_8_29_1
e_1_2_8_24_1
e_1_2_8_47_1
e_1_2_8_25_1
e_1_2_8_46_1
e_1_2_8_26_1
e_1_2_8_49_1
e_1_2_8_27_1
e_1_2_8_48_1
e_1_2_8_3_1
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_43_1
e_1_2_8_21_1
e_1_2_8_42_1
e_1_2_8_22_1
e_1_2_8_45_1
e_1_2_8_23_1
e_1_2_8_44_1
e_1_2_8_41_1
e_1_2_8_40_1
Eddahibi S (e_1_2_8_9_1) 1997; 41
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_39_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_36_1
e_1_2_8_14_1
e_1_2_8_35_1
e_1_2_8_15_1
e_1_2_8_38_1
e_1_2_8_16_1
e_1_2_8_37_1
e_1_2_8_32_1
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_11_1
e_1_2_8_34_1
e_1_2_8_12_1
e_1_2_8_33_1
e_1_2_8_30_1
References_xml – ident: e_1_2_8_24_1
  doi: 10.1038/79226
– ident: e_1_2_8_48_1
  doi: 10.1164/rccm.200509-1361OC
– ident: e_1_2_8_23_1
  doi: 10.1161/hh2401.100426
– ident: e_1_2_8_38_1
  doi: 10.1124/jpet.104.081182
– ident: e_1_2_8_44_1
  doi: 10.1002/path.1711600204
– ident: e_1_2_8_4_1
  doi: 10.1007/s10254-004-0034-4
– ident: e_1_2_8_40_1
  doi: 10.1152/japplphysiol.01028.2005
– ident: e_1_2_8_19_1
  doi: 10.1074/jbc.M702637200
– ident: e_1_2_8_36_1
  doi: 10.1152/ajplung.00234.2007
– ident: e_1_2_8_28_1
  doi: 10.1152/ajplung.1999.277.2.L282
– ident: e_1_2_8_5_1
  doi: 10.1128/MCB.02061-05
– ident: e_1_2_8_8_1
  doi: 10.1172/JCI200112805
– ident: e_1_2_8_20_1
  doi: 10.1253/circj.70.174
– ident: e_1_2_8_49_1
  doi: 10.1164/ajrccm.162.4.9912131
– ident: e_1_2_8_32_1
  doi: 10.1111/j.1476-5381.1996.tb15982.x
– ident: e_1_2_8_33_1
  doi: 10.1161/01.CIR.0000127375.56172.92
– ident: e_1_2_8_34_1
  doi: 10.1038/sj.bjp.0703570
– ident: e_1_2_8_16_1
  doi: 10.1136/jmg.40.12.865
– ident: e_1_2_8_30_1
  doi: 10.1161/01.RES.0000141428.53262.a4
– ident: e_1_2_8_22_1
  doi: 10.1016/j.neulet.2006.08.038
– ident: e_1_2_8_43_1
  doi: 10.1161/01.RES.0000261658.12024.18
– ident: e_1_2_8_46_1
  doi: 10.1016/S0092-8674(03)01014-6
– ident: e_1_2_8_26_1
  doi: 10.1161/01.RES.0000176025.57706.1e
– ident: e_1_2_8_11_1
  doi: 10.1620/tjem.211.309
– ident: e_1_2_8_35_1
  doi: 10.1111/j.1476-5381.1996.tb15760.x
– ident: e_1_2_8_42_1
  doi: 10.1152/ajpcell.00459.2005
– ident: e_1_2_8_7_1
  doi: 10.1172/JCI8678
– ident: e_1_2_8_10_1
  doi: 10.1152/ajplung.00090.2003
– ident: e_1_2_8_21_1
  doi: 10.1097/FJC.0b013e31802df112
– ident: e_1_2_8_3_1
  doi: 10.1097/01.fjc.0000248244.64430.4a
– ident: e_1_2_8_29_1
  doi: 10.1165/rcmb.2005-0163OC
– ident: e_1_2_8_6_1
  doi: 10.1242/jcs.03266
– ident: e_1_2_8_13_1
  doi: 10.1161/01.RES.0000222546.45372.a0
– ident: e_1_2_8_39_1
  doi: 10.1164/rccm.200405-637OC
– ident: e_1_2_8_27_1
  doi: 10.1016/S0891-5849(97)00359-6
– ident: e_1_2_8_2_1
  doi: 10.1161/01.RES.0000111804.34509.94
– ident: e_1_2_8_31_1
  doi: 10.1161/01.RES.0000215809.47923.fd
– ident: e_1_2_8_18_1
  doi: 10.1161/01.RES.0000174287.17953.83
– ident: e_1_2_8_14_1
  doi: 10.1074/jbc.M604195200
– ident: e_1_2_8_12_1
  doi: 10.1002/path.1427
– ident: e_1_2_8_17_1
  doi: 10.1097/FJC.0b013e3181593774
– ident: e_1_2_8_47_1
  doi: 10.1164/rccm.200302-264OC
– ident: e_1_2_8_45_1
  doi: 10.1152/physiol.00053.2005
– ident: e_1_2_8_41_1
  doi: 10.1016/0014-5793(96)00811-3
– ident: e_1_2_8_15_1
  doi: 10.1038/sj.bjp.0706408
– ident: e_1_2_8_25_1
  doi: 10.1152/ajplung.00110.2006
– volume: 41
  start-page: H1173
  year: 1997
  ident: e_1_2_8_9_1
  article-title: Treatment with 5‐HT potentiates development of pulmonary hypertension in chronically hypoxic rats
  publication-title: Am J Physiol
  contributor:
    fullname: Eddahibi S
– ident: e_1_2_8_37_1
  doi: 10.1038/sj.bjp.0702841
SSID ssj0014775
Score 2.1663878
Snippet Background and purpose: While the 5‐HT and Rho‐kinase (ROCK) pathways have been implicated in the development of pulmonary arterial hypertension (PAH), the...
SourceID crossref
SourceType Aggregation Database
StartPage 606
Title Novel interactions between the 5‐HT transporter, 5‐HT 1B receptors and Rho kinase in vivo and in pulmonary fibroblasts
Volume 155
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtNAEF5F7YULovwIaEF7gF4SQ51d766PDaWKkFr14ErlFHnrsQiU2Gp-pPbEI_RB-lQ8CbM_2WxKD4WLZW1iR858mp0Zf_MNIe84q0sJNUu06pcJzxDG2kxzN5u3qtSeBCtgenQshqf8y1l21uncRqyl-Ux_OL--t6_kf6yKa2hX0yX7D5YNN8UFPEf74hEtjMcH2fi4WcCFVXy4dP0J08C7MvFkFpgMw8LMgvAq5tZGa5-lgy46Pmjt5B3bsfit6f4YT3CHM_WQxXjReJWmbju_wMczVLsaE-1GY_DttKDuqiRFkhTtSh474hyPHZtjVY61NGRXjz3qxmxgCJtFKPEewM926l6tfF0rXBhaVuKrG0tnLBPMb5z7Bed_uRQJ-uB0zUE7IV-PRB65W7Enop1buK7NvzYFJwGvv7eOOss8j3ZNe_vOnhiYivYdPVMjvNpN7GSmn2-zL_MMU_3N_cHB4DC8teJSuokZ_sF8owVe_zH-9SgEimKZ4gl57JMQuu8QtUU6MHlKdk-cma56tFg15U17dJeeRAZ8Rq4t7GgMO-phRxF2NPv962ZY0AhwveVaOqABaBQRRRFo1AEN70cN0Owyngeg0Qhoz8np4efi0zDxIzySc8w0Zkmu6rSSaZ5rBv20LHUlWS4UJhG8xsQERI3hozCqiTrVtU6V4CZnqSpMozirSvaCbEyaCbwkNAOQGqqsZHnJgZneUBPNM5VJkFyrV-T98l8dtU6pZXSf9V4_8Hvb5NEKtTtkY3Y5hzcYgM70W2_3PyoIhjI
link.rule.ids 315,786,790,27957,27958
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Novel+interactions+between+the+5%E2%80%90HT+transporter%2C+5%E2%80%90HT+1B+receptors+and+Rho+kinase+in+vivo+and+in+pulmonary+fibroblasts&rft.jtitle=British+journal+of+pharmacology&rft.au=Mair%2C+K+M&rft.au=MacLean%2C+M+R&rft.au=Morecroft%2C+I&rft.au=Dempsie%2C+Y&rft.date=2009-01-29&rft.issn=0007-1188&rft.eissn=1476-5381&rft.volume=155&rft.issue=4&rft.spage=606&rft.epage=616&rft_id=info:doi/10.1038%2Fbjp.2008.310&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_bjp_2008_310
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1188&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1188&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1188&client=summon